# Artiva Biotherapeutics, Inc.: Form 8-K, filed Dec 12, 2025

- Company: [Artiva Biotherapeutics, Inc.](/companies/artv.md) (CIK 1817241)
- Form: 8-K
- Filed: 2025-12-12
- Accepted by EDGAR: Dec 12, 2025, 17:23 ET
- Period: 2025-12-10
- Accession: 0001193125-25-317784
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1817241/000119312525317784/artv-20251210.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817241/000119312525317784/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817241/000119312525317784/artv-20251210.htm

Filed Dec 12, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-317784. Last ingested by Listed: Nov 10, 2026, 01:58 ET. No prices; not investment advice.